aluminum sulfate has been researched along with Experimental Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cox, JC; Drane, D; Edwards, SJ; Elmer, H; Fernando, GJ; Frazer, IH; Malcolm, KM; Malliaros, J; Stewart, TJ | 1 |
Bhattachary-Chatterjee, M; Chakraborty, M; Chatterjee, SK; Das, R; Foon, KA; Nath Baral, R; Zeytin, H | 1 |
1 review(s) available for aluminum sulfate and Experimental Neoplasms
Article | Year |
---|---|
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
1 trial(s) available for aluminum sulfate and Experimental Neoplasms
Article | Year |
---|---|
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
1 other study(ies) available for aluminum sulfate and Experimental Neoplasms
Article | Year |
---|---|
ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccines.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neoplasm; Antibody Formation; Cancer Vaccines; Cell Line; Cholesterol; Chromium Radioisotopes; Drug Combinations; Female; Hypersensitivity, Delayed; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Oncogene Proteins, Viral; Phospholipids; Repressor Proteins; Saponins; T-Lymphocytes, Cytotoxic; Th1 Cells; Th2 Cells; Vaccines, Synthetic | 2004 |